PPARG and cancer: Interestingly, a recently published report, that uses amathematical model to study the interactions of the AA metabolic network, hasrevealed that a dual inhibitor against LOX/COX is more effective than acombination of single COX and LOX inhibitors [84].A successful attempt to reduce cell growth in cancer, through the AA metabolicpathway, may have great potency if involves inhibition of both the LOX and COX pathways and activationof PPARγ.